The implications of alternative pre-mRNA splicing in cell signal transduction.


Journal

Experimental & molecular medicine
ISSN: 2092-6413
Titre abrégé: Exp Mol Med
Pays: United States
ID NLM: 9607880

Informations de publication

Date de publication:
04 2023
Historique:
received: 12 11 2022
accepted: 27 01 2023
revised: 05 01 2023
medline: 10 5 2023
pubmed: 4 4 2023
entrez: 3 4 2023
Statut: ppublish

Résumé

Cells produce multiple mRNAs through alternative splicing, which ensures proteome diversity. Because most human genes undergo alternative splicing, key components of signal transduction pathways are no exception. Cells regulate various signal transduction pathways, including those associated with cell proliferation, development, differentiation, migration, and apoptosis. Since proteins produced through alternative splicing can exhibit diverse biological functions, splicing regulatory mechanisms affect all signal transduction pathways. Studies have demonstrated that proteins generated by the selective combination of exons encoding important domains can enhance or attenuate signal transduction and can stably and precisely regulate various signal transduction pathways. However, aberrant splicing regulation via genetic mutation or abnormal expression of splicing factors negatively affects signal transduction pathways and is associated with the onset and progression of various diseases, including cancer. In this review, we describe the effects of alternative splicing regulation on major signal transduction pathways and highlight the significance of alternative splicing.

Identifiants

pubmed: 37009804
doi: 10.1038/s12276-023-00981-7
pii: 10.1038/s12276-023-00981-7
pmc: PMC10167241
doi:

Substances chimiques

RNA Precursors 0
Proteins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

755-766

Informations de copyright

© 2023. The Author(s).

Références

BMC Med Genet. 2012 Apr 10;13:26
pubmed: 22487062
J Biol Chem. 1996 May 31;271(22):13221-7
pubmed: 8675499
Sci Rep. 2019 Jan 23;9(1):335
pubmed: 30674940
BMC Mol Biol. 2010 Apr 30;11:32
pubmed: 20433698
Nat Rev Cancer. 2007 Mar;7(3):182-91
pubmed: 17318211
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Front Immunol. 2019 Dec 16;10:2872
pubmed: 31921137
Nat Rev Mol Cell Biol. 2013 Jul;14(7):416-29
pubmed: 23719536
Br J Cancer. 2004 Aug 16;91(4):707-13
pubmed: 15226763
J Biol Chem. 2001 Jan 12;276(2):1311-6
pubmed: 11032829
Cell Rep. 2012 Feb 23;1(2):110-7
pubmed: 22545246
Gene. 2004 Apr 14;330:101-14
pubmed: 15087129
Cell Commun Signal. 2021 Aug 14;19(1):86
pubmed: 34391444
Signal Transduct Target Ther. 2022 Mar 24;7(1):95
pubmed: 35332121
Genome Biol. 2021 Jun 17;22(1):182
pubmed: 34140043
Nucleic Acids Res. 2007;35(1):125-31
pubmed: 17158149
EMBO J. 2005 Aug 3;24(15):2792-802
pubmed: 16001081
Signal Transduct Target Ther. 2021 Feb 24;6(1):78
pubmed: 33623018
J Immunol. 2006 Mar 1;176(5):3010-8
pubmed: 16493059
J Biol Chem. 2004 May 21;279(21):22765-72
pubmed: 14996829
Nat Cell Biol. 2014 Oct;16(10):1004-15, 1-13
pubmed: 25241036
Int J Mol Med. 2021 Jun;47(6):
pubmed: 33907821
Neurology. 2000 May 9;54(9):1874-5
pubmed: 10802807
Eur J Hum Genet. 2018 Aug;26(8):1151-1158
pubmed: 29706644
Biochem J. 2009 Jan 1;417(1):15-27
pubmed: 19061484
EMBO J. 1994 Nov 15;13(22):5483-95
pubmed: 7957114
Oncogene. 2007 Jul 26;26(34):4889-96
pubmed: 17310997
Nat Methods. 2013 Dec;10(12):1177-84
pubmed: 24185837
Front Cell Dev Biol. 2021 Mar 26;9:652273
pubmed: 33842479
Gene. 2002 Jan 9;282(1-2):151-8
pubmed: 11814687
Leukemia. 2021 Oct;35(10):2875-2884
pubmed: 34480104
Front Immunol. 2020 Sep 11;11:2189
pubmed: 33042133
Front Immunol. 2018 Dec 06;9:2879
pubmed: 30574148
Int J Cancer. 2004 Nov 10;112(3):420-5
pubmed: 15382067
Biochem J. 2004 Mar 1;378(Pt 2):325-34
pubmed: 14613484
PLoS One. 2012;7(7):e40250
pubmed: 22792253
Mol Med Rep. 2018 Jan;17(1):699-704
pubmed: 29115550
Eur J Hum Genet. 2011 Aug;19(8):875-81
pubmed: 21407258
Cell Div. 2007 Feb 13;2:7
pubmed: 17298674
Nat Rev Clin Oncol. 2020 Aug;17(8):457-474
pubmed: 32303702
Int J Mol Sci. 2016 Jan 16;17(1):
pubmed: 26784191
Front Cell Dev Biol. 2021 Jan 21;9:631623
pubmed: 33585487
Genes (Basel). 2021 Feb 28;12(3):
pubmed: 33670833
BMC Mol Biol. 2006 Mar 23;7:13
pubmed: 16553965
Genome Biol. 2020 Feb 7;21(1):30
pubmed: 32033565
Cell Biosci. 2012 Mar 15;2:9
pubmed: 22420375
Ann Neurol. 2005 Dec;58(6):829-39
pubmed: 16315267
Signal Transduct Target Ther. 2021 Nov 26;6(1):402
pubmed: 34824210
Nat Immunol. 2004 Apr;5(4):401-9
pubmed: 15021879
Mol Endocrinol. 2009 Nov;23(11):1758-75
pubmed: 19628582
EMBO J. 2003 Aug 15;22(16):4237-48
pubmed: 12912921
Genes Cells. 1999 Oct;4(10):583-91
pubmed: 10583507
Am J Med Genet A. 2006 Jan 1;140(1):31-9
pubmed: 16333836
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Blood. 2011 Aug 18;118(7):1806-17
pubmed: 21772053
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30
pubmed: 22992590
Cell Cycle. 2013 Nov 15;12(22):3547-54
pubmed: 24091628
Mol Genet Genomic Med. 2019 Sep;7(9):e878
pubmed: 31325247
Genet Med. 2022 Jan;24(1):130-145
pubmed: 34906502
EMBO J. 2001 Feb 1;20(3):480-90
pubmed: 11157754
Front Mol Biosci. 2021 Jul 08;8:711710
pubmed: 34307464
Int J Dev Neurosci. 2009 Aug;27(5):501-10
pubmed: 19375497
J Virol. 1998 May;72(5):3958-64
pubmed: 9557682
BMC Med Genomics. 2021 Mar 19;14(1):87
pubmed: 33740971
Neurobiol Aging. 2013 Sep;34(9):2234.e9-12
pubmed: 23587639
JAKSTAT. 2013 Jul 1;2(3):e24574
pubmed: 24069558
Blood. 2014 May 1;123(18):2816-25
pubmed: 24574459
Gene. 2012 Nov 10;509(2):215-22
pubmed: 22939869
Mech Dev. 2011 Sep-Dec;128(7-10):442-56
pubmed: 21914475
Science. 2011 Mar 11;331(6022):1289-95
pubmed: 21393538
J Cancer Metastasis Treat. 2020;6:
pubmed: 33521321
J Cell Biol. 2013 Feb 18;200(4):443-58
pubmed: 23420872
EMBO J. 2000 Feb 1;19(3):392-9
pubmed: 10654938
Blood. 2015 Oct 1;126(14):1731-2
pubmed: 26429967
J Biol Chem. 2010 Nov 26;285(48):37159-69
pubmed: 20858893
Am J Hum Genet. 2002 Jan;70(1):11-9
pubmed: 11741193
Genes Dev. 2010 Jan 1;24(1):72-85
pubmed: 20048001
J Virol. 2006 May;80(9):4227-41
pubmed: 16611882
Hum Mol Genet. 2005 Nov 15;14(22):3379-88
pubmed: 16203740
Ther Adv Med Oncol. 2010 Jul;2(4):237-50
pubmed: 21789137
Oncol Lett. 2019 Nov;18(5):4377-4384
pubmed: 31611946
Oncogenesis. 2019 Oct 9;8(10):59
pubmed: 31597912
Oncogene. 2008 Dec 4;27(53):6770-81
pubmed: 18695674
Wiley Interdiscip Rev RNA. 2012 Jan-Feb;3(1):1-12
pubmed: 21898828
Eur J Hum Genet. 2014 Jun;22(6):833-6
pubmed: 24169521
J Allergy Clin Immunol. 2017 Jul;140(1):268-271.e6
pubmed: 27956217
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Nucleic Acids Res. 2014 Apr;42(6):4019-30
pubmed: 24442672
Nat Struct Mol Biol. 2018 Oct;25(10):928-939
pubmed: 30250226
J Biol Chem. 2001 Jun 1;276(22):19390-5
pubmed: 11279196
Nat Rev Genet. 2014 Oct;15(10):689-701
pubmed: 25112293
Dev Growth Differ. 2010 May;52(4):335-42
pubmed: 20148926
Gene. 2006 Apr 12;371(1):121-9
pubmed: 16480837
Cell Chem Biol. 2017 Mar 16;24(3):252-280
pubmed: 28286127
Annu Rev Biochem. 2015;84:291-323
pubmed: 25784052
J Biol Chem. 2008 May 23;283(21):14345-54
pubmed: 18378682
Front Cell Dev Biol. 2019 Aug 07;7:154
pubmed: 31448275
PLoS One. 2015 Aug 11;10(8):e0135017
pubmed: 26263164
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21441581
Nat Commun. 2016 Jun 13;7:ncomms11840
pubmed: 27291620
Biochem Biophys Rep. 2016 Mar 03;6:24-31
pubmed: 28018981
PLoS One. 2010 Aug 13;5(8):e12165
pubmed: 20730051
Protein Sci. 2018 Dec;27(12):1984-2009
pubmed: 30267440
Annu Rev Med. 2015;66:311-28
pubmed: 25587654
Cell Commun Signal. 2018 Mar 20;16(1):11
pubmed: 29558958
Traffic. 2014 Sep;15(9):946-60
pubmed: 24903907
J Clin Invest. 2020 Apr 1;130(4):2129-2145
pubmed: 31945016
Annu Rev Biochem. 2022 Jun 21;91:571-598
pubmed: 35303793
J Exp Med. 2021 Nov 1;218(11):
pubmed: 34473196
J Biol Chem. 1995 Oct 20;270(42):25028-36
pubmed: 7559633
J Immunol. 2002 Jun 1;168(11):5629-37
pubmed: 12023360
PLoS One. 2015 Jan 24;10(1):e0116636
pubmed: 25617626
Annu Rev Genet. 2018 Nov 23;52:65-87
pubmed: 30183404
Semin Cell Dev Biol. 2011 Sep;22(7):673-80
pubmed: 21864699
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
Genes Dev. 2003 Feb 15;17(4):419-37
pubmed: 12600935
Oncogene. 2002 Sep 5;21(39):6007-16
pubmed: 12203113
RNA. 2020 Oct;26(10):1389-1399
pubmed: 32522889
PLoS One. 2012;7(11):e49453
pubmed: 23166673
Gene. 2004 Mar 3;327(2):141-52
pubmed: 14980711
Oncogenesis. 2021 Jan 5;10(1):8
pubmed: 33431808
Cell. 1992 Jan 24;68(2):365-75
pubmed: 1531115
Oncogenesis. 2016 Jan 04;4:e184
pubmed: 26727576
Mol Cell. 2006 Jul 7;23(1):61-70
pubmed: 16797197
N Engl J Med. 2002 May 16;346(20):1513-21
pubmed: 12015390
J Biol Chem. 2005 Jan 14;280(2):1678-87
pubmed: 15522867
Onco Targets Ther. 2018 Apr 11;11:2063-2073
pubmed: 29695914
Bosn J Basic Med Sci. 2018 Feb 20;18(1):8-20
pubmed: 29274272
Front Genet. 2012 Jul 06;3:119
pubmed: 22833753
Cancer Discov. 2011 Nov;1(6):481-6
pubmed: 22348200
Biochim Biophys Acta. 2016 Jan;1862(1):46-55
pubmed: 26459048
RNA. 1995 Sep;1(7):663-80
pubmed: 7585252
Nucleic Acids Res. 2022 Aug 26;50(15):8658-8673
pubmed: 35699208
Oncotarget. 2016 Oct 4;7(40):66310-66322
pubmed: 27579619
Cancer Cell. 2002 May;1(4):369-79
pubmed: 12086851
J Biol Chem. 1999 Jan 8;274(2):703-9
pubmed: 9873005
FEBS Lett. 2004 Dec 3;578(1-2):157-62
pubmed: 15581634
J Cell Biol. 2008 Jun 16;181(6):913-20
pubmed: 18559665
J Biol Chem. 2005 Mar 4;280(9):7444-51
pubmed: 15618216
Curr Opin Syst Biol. 2017 Feb;1:16-24
pubmed: 29104946
Annu Rev Biochem. 2019 Jun 20;88:577-604
pubmed: 30566373
Genes Dev. 2016 Jan 1;30(1):1-17
pubmed: 26728553
Hum Mol Genet. 2018 Aug 1;27(R2):R234-R241
pubmed: 29767702
PLoS Genet. 2014 Apr 10;10(4):e1004289
pubmed: 24722255
J Hepatol. 2021 Sep;75(3):623-633
pubmed: 33964370
J Med Genet. 2002 Oct;39(10):754-7
pubmed: 12362034
Science. 1993 Sep 24;261(5129):1744-6
pubmed: 7690989
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9869-74
pubmed: 24961374
Front Immunol. 2021 Aug 09;12:716469
pubmed: 34434197
Oncol Lett. 2017 Mar;13(3):1944-1948
pubmed: 28454348
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
Front Cell Dev Biol. 2021 Oct 08;9:673873
pubmed: 34692669
Signal Transduct Target Ther. 2022 Jan 3;7(1):3
pubmed: 34980884
PLoS One. 2015 May 18;10(5):e0127243
pubmed: 25984943
Nat Rev Mol Cell Biol. 2005 May;6(5):386-98
pubmed: 15956978
Mol Cell Biol. 2014 Jun;34(12):2235-48
pubmed: 24710278
Cancer Res. 2009 Sep 1;69(17):6790-8
pubmed: 19706761
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Trends Genet. 2002 Apr;18(4):186-93
pubmed: 11932019
J Hematol Oncol. 2020 Dec 4;13(1):165
pubmed: 33276800
Int J Mol Sci. 2016 Mar 22;17(3):406
pubmed: 27011172

Auteurs

Sunkyung Choi (S)

Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon, 34134, Republic of Korea.

Namjoon Cho (N)

Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon, 34134, Republic of Korea.

Kee K Kim (KK)

Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon, 34134, Republic of Korea. kimkk@cnu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH